Stephanie Marks
Keine laufenden Positionen mehr
Profil
Stephanie Marks worked as the Head of Investor Relations at NxStage Medical, Inc. and Insulet Corp.
Ehemalige bekannte Positionen von Stephanie Marks
| Unternehmen | Position | Ende |
|---|---|---|
| INSULET CORPORATION | Investor Relations Kontakt | - |
| NXSTAGE MEDICAL, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INSULET CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NxStage Medical, Inc.
 NxStage Medical, Inc. Medical SpecialtiesHealth Technology NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis. The Services segment includes revenues from dialysis services provided to patients at its recently opened NxStage Kidney Care dialysis centers. The company was founded by Jeffrey H. Burbank in December 1998 and is headquartered in Waltham, MA. | Health Technology |
